NCT00639028 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Brasseur JL, Morvan G, Godoc B
[Dynamic ultrasonography]. J Radiol. 2005 Dec;86(12 Pt 2):1904-10. Review. French.
Brasseur JL, Tardieu M
[Accurate use of imaging in ankle sprain]. JBR-BTR. 1999 Apr;82(2):63-8. Review. French.
Braun BL
Effects of ankle sprain in a general clinic population 6 to 18 months after medical evaluation. Arch Fam Med. 1999 Mar-Apr;8(2):143-8.
Hiller CE, Refshauge KM, Bundy AC, Herbert RD, Kilbreath SL
The Cumberland ankle instability tool: a report of validity and reliability testing. Arch Phys Med Rehabil. 2006 Sep;87(9):1235-41.
Picard F, Tourné Y, Montbarbon E, Saragaglia D
[Ankle trauma. Diagnostic orientation]. Rev Prat. 1995 Nov 15;45(18):2335-42. French.
Raatikainen T, Putkonen M, Puranen J
Arthrography, clinical examination, and stress radiograph in the diagnosis of acute injury to the lateral ligaments of the ankle. Am J Sports Med. 1992 Jan-Feb;20(1):2-6.

Comparative Study of Two Radiological Modalities, Ultrasonography Versus Stress Radiography, in the Urgent Care and Prognosis of Lateral Ankle Sprains.

Details for clinical trial NCT00639028

Clinical trial NCT00639028 - References